Form 4: Vicarious Surgical Director Granted Stock Options

Vicarious Surgical Inc. Director Randolph A. Clark was granted 8,003 stock options with a $7.61 exercise price, vesting by June 27, 2026.

Summary

• Director Randolph A. Clark of Vicarious Surgical Inc. (RBOT) was granted 8,003 stock options on June 27, 2025.
• The stock options have an exercise price of $7.61 per share.
• The options are for Class A Common Stock and expire on June 26, 2035.
• The shares underlying these options will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier.
• Vesting is subject to the Reporting Person's continued service through the applicable vesting date.
• Following this transaction, Randolph A. Clark directly beneficially owns 8,003 derivative securities.

Sentiment

Score: 7

Explanation: The grant of stock options to a director is a positive step for aligning management incentives with shareholder interests, though it is a routine compensation event.

Positives

• The grant of 8,003 stock options to Director Randolph A. Clark aligns his interests with long-term shareholder value.
• The options have a long expiration date of June 26, 2035, providing a sustained incentive for the director.

Future Outlook

The vesting schedule for the granted stock options, contingent on continued service through June 27, 2026, indicates a commitment to long-term retention of Director Randolph A. Clark.

Industry Context

The grant of stock options to a director is a common practice in the biotechnology and medical device industry to incentivize long-term performance and align management interests with shareholder value, similar to practices at companies like Intuitive Surgical or Stryker.

Comparison to Industry Standards

• The grant of stock options to a director is a standard component of executive compensation packages across the medical technology sector, comparable to equity incentives offered by peers such as Intuitive Surgical (ISRG) or Medtronic (MDT) to retain key talent and align their interests with company performance.
• The vesting schedule tied to continued service is also a common mechanism to ensure long-term commitment, consistent with corporate governance best practices in the industry.

Related Party Transactions

• Grant of 8,003 stock options to Director Randolph A. Clark.

Stakeholder Impact

• Shareholders: Potential long-term value creation if options are exercised and stock price increases, aligning the director's interests with shareholder returns.
• Employees: This transaction reflects standard compensation practices for directors within the company.

Next Steps

• The stock options are scheduled to vest on June 27, 2026, or earlier, subject to the director's continued service.

Key Dates

Recommendation

The filing details a routine stock option grant to a director, which is a standard compensation practice and does not provide sufficient new information to warrant a change in investment recommendation. It primarily serves to align the director's interests with long-term shareholder value.

Keywords

Vicarious Surgical, RBOT, Stock Option, Director, Equity Grant, Executive Compensation, Insider Transaction, Form 4